(Q40464533)

English

Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902.

scientific article published on November 2006

Statements

Phase II study of etoposide and cisplatin with concurrent twice-daily thoracic radiotherapy followed by irinotecan and cisplatin in patients with limited-disease small-cell lung cancer: West Japan Thoracic Oncology Group 9902. (English)
Yukito Ichinose
Kazuhiko Nakagawa
Shunichi Negoro
Masahiro Fukuoka
West Japan Thoracic Oncology Group 9902

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit